Boehringer Ingelheim Semintra (telmisartan oral solution) 10 mg/mL

Recall announced June 30, 2023 by Boehringer Ingelheim Animal Health USA Inc, posted by the U.S. Food and Drug Administration (FDA). Reason: Out of specification for pH and precipitation formation. It affects cats. The agency has closed this recall.

Brands
Semintra
Where sold
Nationwide.
Last updated
November 20, 2026

Products included

Read the official notice. Always compare the codes on your package with the official notice. It is the final word.

Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.

See all pet recalls